|
Re: Another reason
|
7
|
Resverlogix Corp.
|
Jan 11, 2022 01:09PM
|
|
RPRX HAS $450 MILLION ( ROYALTY PHARMA )
|
2
|
Resverlogix Corp.
|
Jan 08, 2022 06:18PM
|
|
Re: Snow Job
|
1
|
Resverlogix Corp.
|
Dec 22, 2021 11:24PM
|
|
Re: Snow Job
|
|
Resverlogix Corp.
|
Dec 22, 2021 11:23PM
|
|
Re: Snow Job
|
1
|
Resverlogix Corp.
|
Dec 22, 2021 11:23PM
|
|
Re: Snow Job
|
1
|
Resverlogix Corp.
|
Dec 22, 2021 11:23PM
|
|
Re: Momentum Players and Agoracom.com’s Rules
|
1
|
Resverlogix Corp.
|
Dec 21, 2021 11:49AM
|
|
Update on the 16th
|
|
Resverlogix Corp.
|
Dec 18, 2021 02:39PM
|
|
Re: Question for posters
|
2
|
Resverlogix Corp.
|
Dec 10, 2021 07:19PM
|
|
Re: Question for posters
|
2
|
Resverlogix Corp.
|
Dec 09, 2021 07:39PM
|
|
Re: Time keeps ticking
|
2
|
Resverlogix Corp.
|
Nov 19, 2021 12:48AM
|
|
Re: 0.48 CAD −0.040 (7.69%)
|
1
|
Resverlogix Corp.
|
Nov 15, 2021 10:00PM
|
|
Re: 0.48 CAD −0.040 (7.69%)
|
2
|
Resverlogix Corp.
|
Nov 15, 2021 10:00PM
|
|
Re: Resverlogix to Present at Upcoming Conferences
|
2
|
Resverlogix Corp.
|
Oct 13, 2021 08:25PM
|
|
Re: MERK
|
2
|
Resverlogix Corp.
|
Sep 30, 2021 08:38AM
|
|
Re: MERK
|
|
Resverlogix Corp.
|
Sep 30, 2021 08:35AM
|
|
MERK
|
4
|
Resverlogix Corp.
|
Sep 30, 2021 08:25AM
|
|
Re: Zenith Epigenetics and Newsoara Announce Initiation of a Randomized Phase 2b Metastatic Castration-Resistant Prostate Cancer Study
|
1
|
Resverlogix Corp.
|
Sep 26, 2021 05:07PM
|
|
Re: The latest numbers for Alberta.
|
1
|
Resverlogix Corp.
|
Sep 16, 2021 09:19PM
|
|
Re: Providence Therapeutics
|
4
|
Resverlogix Corp.
|
Sep 14, 2021 12:41PM
|
